| Margaret R Puelle, MD | |
|
300 Crittenden Blvd Box Psych Education, Rochester, NY 14642-3377 | |
| (585) 274-1278 | |
| (267) 282-3814 |
| Full Name | Margaret R Puelle |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 300 Crittenden Blvd Box Psych Education, Rochester, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073019378 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 317660 (New York) | Primary |
| Entity Name | University Of Rochester |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710226824 PECOS PAC ID: 5799699088 Enrollment ID: O20031201000019 |
News Archive
Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that its researchers have demonstrated the ability of the Aethlon Hemopurifier® to capture immunosuppressive exosomes derived from individuals with metastatic melanoma.
Despite the high erectile dysfunction prevalence most patients receive no treatment, according to a new US study, presented at the 28th Annual EAU Congress. Undertreatment of ED continues to be common, even though the treatments have a proven efficacy and quality of life impact.
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, and Jiangsu Hengrui Medicine Co., Ltd., a leading Chinese pharmaceutical company, today announced that Shanghai ChemPartner, a wholly owned subsidiary of ShangPharma, and Hengrui have entered into a strategic partnership for the development of novel therapeutic monoclonal antibodies.
Researchers at Sandia National Laboratories and the University of New Mexico are comparing supercomputer simulations of blast waves on the brain with clinical studies of veterans suffering from mild traumatic brain injuries (TBIs) to help improve helmet designs.
› Verified 6 days ago
| Entity Name | University Of Rochester Department Of Psychiatry Clinical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326088808 PECOS PAC ID: 3173420429 Enrollment ID: O20031216000276 |
News Archive
Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that its researchers have demonstrated the ability of the Aethlon Hemopurifier® to capture immunosuppressive exosomes derived from individuals with metastatic melanoma.
Despite the high erectile dysfunction prevalence most patients receive no treatment, according to a new US study, presented at the 28th Annual EAU Congress. Undertreatment of ED continues to be common, even though the treatments have a proven efficacy and quality of life impact.
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, and Jiangsu Hengrui Medicine Co., Ltd., a leading Chinese pharmaceutical company, today announced that Shanghai ChemPartner, a wholly owned subsidiary of ShangPharma, and Hengrui have entered into a strategic partnership for the development of novel therapeutic monoclonal antibodies.
Researchers at Sandia National Laboratories and the University of New Mexico are comparing supercomputer simulations of blast waves on the brain with clinical studies of veterans suffering from mild traumatic brain injuries (TBIs) to help improve helmet designs.
› Verified 6 days ago
| Entity Name | University Dermatology Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609802362 PECOS PAC ID: 5698736460 Enrollment ID: O20041025000732 |
News Archive
Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that its researchers have demonstrated the ability of the Aethlon Hemopurifier® to capture immunosuppressive exosomes derived from individuals with metastatic melanoma.
Despite the high erectile dysfunction prevalence most patients receive no treatment, according to a new US study, presented at the 28th Annual EAU Congress. Undertreatment of ED continues to be common, even though the treatments have a proven efficacy and quality of life impact.
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, and Jiangsu Hengrui Medicine Co., Ltd., a leading Chinese pharmaceutical company, today announced that Shanghai ChemPartner, a wholly owned subsidiary of ShangPharma, and Hengrui have entered into a strategic partnership for the development of novel therapeutic monoclonal antibodies.
Researchers at Sandia National Laboratories and the University of New Mexico are comparing supercomputer simulations of blast waves on the brain with clinical studies of veterans suffering from mild traumatic brain injuries (TBIs) to help improve helmet designs.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Margaret R Puelle, MD 300 Crittenden Blvd Box Psych Education, Rochester, NY 14642-3377 Ph: (585) 274-1278 | Margaret R Puelle, MD 300 Crittenden Blvd Box Psych Education, Rochester, NY 14642-3377 Ph: (585) 274-1278 |
News Archive
Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that its researchers have demonstrated the ability of the Aethlon Hemopurifier® to capture immunosuppressive exosomes derived from individuals with metastatic melanoma.
Despite the high erectile dysfunction prevalence most patients receive no treatment, according to a new US study, presented at the 28th Annual EAU Congress. Undertreatment of ED continues to be common, even though the treatments have a proven efficacy and quality of life impact.
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, and Jiangsu Hengrui Medicine Co., Ltd., a leading Chinese pharmaceutical company, today announced that Shanghai ChemPartner, a wholly owned subsidiary of ShangPharma, and Hengrui have entered into a strategic partnership for the development of novel therapeutic monoclonal antibodies.
Researchers at Sandia National Laboratories and the University of New Mexico are comparing supercomputer simulations of blast waves on the brain with clinical studies of veterans suffering from mild traumatic brain injuries (TBIs) to help improve helmet designs.
› Verified 6 days ago
Kevin Paul Brazill, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2613 W Henrietta Rd, Rochester, NY 14623 Phone: 585-279-4999 | |
Jason Don Crowley, M.D., M.P.H. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 100 Pinewild Dr Ste A2, Rochester, NY 14606 Phone: 585-368-6700 | |
Sanjay Kevin Anandaram, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1415 Portland Ave Ste 445, Rochester, NY 14621 Phone: 585-922-4371 Fax: 585-922-7485 | |
Cameron Elizabeth Houle, FNP-C Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 919 Westfall Rd Ste 100, Rochester, NY 14618 Phone: 585-341-7500 | |
Dr. Wendy Rosen, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 11 North Goodman St. Room #24, Rochester, NY 14607 Phone: 585-473-8180 Fax: 585-473-8180 | |
Dr. Julie L Fudge, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 370 Westminster Rd, Rochester, NY 14607 Phone: 585-241-3648 | |
Irene H Richard, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 919 Westfall Rd, Bldg C, Suite 220, Rochester, NY 14618 Phone: 585-341-7500 Fax: 585-341-7510 |